The Hormone Wars: Small Business and Patients Duke it Out Against Big Pharma and Win

bottom-link">affected -- menopausal women and andropausal men;
The Court's ruling for patient access to compoundedthe Autistic community; men and women with HIV or
medicines ensures that patients and physicians willAIDS; young children with gastroesophageal reflux
continue to have access to vital medicines includingdisease (GERD); hospice and nursing home patients;
bio-identical hormones.This was a big victory forpeople who are very sensitive to dyes and additives
patients who rely on customized medicines, especiallyin medicines, as well as head trauma victims whose
for women taking bio-identical hormone therapy.lives can be saved by compounded bio-identicals.
Advocates including small pharmacies and makers ofIt all started when last October of 2006, out of the
alternative therapies including T.S. Wiley.blue, Wyeth (WYE), filed a complaint with the federal
A ruling by U.S. District Court Judge Robert Junell inFDA to take action against the small pharmacies
August indicate that patients and physicians havemaking bioidentical hormones from soy and other
won the battle against Big Pharma, and therefore willplant materials. Initially there was concern of the
continue to have access to vital compoundeddangers of prescription hormones for women thanks
medicines. This victory for patients who rely onto a major study by the National Institutes of Health
customized medicines, is especially sweet for women(NIH) known as the Women's Health Initiative (WHI).
taking bio-identical hormone therapy. Small pharmaciesIt suggested that taking hormones made by Wyeth
and makers of alternative therapies includingcould lead to increased risk of heart problems and
developers like T.S. Wiley (the Wiley Protocol)breast cancer.
bio-identical hormone replacement therapy, doctors,Recently a new study was published in the Journal of
patients, and other industry organizations includingthe American Medical Association, mentioning that the
compounding pharmacists stood up to this legislationrisks were overstated. As synthetic hormones known
and fought hard to win.as Premarin and PremPro were deemed dangerous,
"It is in the best interest of public health," ruled Junell,the assumption among women using bio-identical
to uphold the legality of compounded drugs. He alsoregimens is that they are actually doing something
said that this legislation passed by Congress exempts"safer."
compounding pharmacies from such detailed FederalAs some experts pointed out, the WHI never looked
Drug Administration (FDA) inspections. "It is notat hormones, but only drugs with "hormone-like"
feasible, either economically or time-wise, for theeffects that were dosed in a regimen far from that
needed medications to be subjected to the FDAof human replacement.
approval process."The fact that the Court ruled in favor of patient
This is good news for women on new alternativeaccess to compounded medicines ensures that
therapies such as compounded bio-identicals becausepatients and physicians will continue to have access
this battle over hormones for women affects a hugeto vital compounded medicines. This will also will allow
market. And there are over 40 million women in themore research and clinical trials to take place on
U.S. from the age of 40 to 60. Around 25 millionbio-identical hormones. This could prove that Wiley's
women annually go into menopause. It is estimatedrevolutionary discovery is accurate - the fact that it's
that by the year 2030, that number will increase tothe rhythm that matters in the accurate physiological
47 million women per year.replacement of hormones without side-effects for
Advocates like Wiley, a medical theorist in the field ofwomen in the second half of life.
environmental endocrinology and a writer andWiley's findings may have important implications
researcher on the use of hormones, testified on Aprilacross a wide range of areas, from the treatment of
19, 2007 before the Special Committee on Aging atmenopause and anti-aging to all of the other diseases
the United States Senate. Wiley's in depth testimonyof aging such as heart disease and stroke, Type II
is available in the Library of Congress.diabetes, cancer and Alzheimer's disease.
This testimony sites those who would have been